Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
160M
-
Number of holders
-
71
-
Total 13F shares, excl. options
-
36.8M
-
Shares change
-
+428K
-
Total reported value, excl. options
-
$310M
-
Value change
-
+$4.14M
-
Number of buys
-
30
-
Number of sells
-
-27
-
Price
-
$8.41
Significant Holders of Cogent Biosciences, Inc. - Common Stock, $0.001 par value (COGT) as of Q3 2021
79 filings reported holding COGT - Cogent Biosciences, Inc. - Common Stock, $0.001 par value as of Q3 2021.
Cogent Biosciences, Inc. - Common Stock, $0.001 par value (COGT) has 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.8M shares
of 160M outstanding shares and own 22.94% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (3.19M shares), BlackRock Inc. (2.73M shares), JANUS HENDERSON GROUP PLC (2.49M shares), Candriam Luxembourg S.C.A. (1.93M shares), COMMODORE CAPITAL LP (1.91M shares), Ally Bridge Group (NY) LLC (1.62M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.6M shares), VANGUARD GROUP INC (1.6M shares), Fairmount Funds Management LLC (1.56M shares), and BVF INC/IL (1.53M shares).
This table shows the top 71 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.